The performance failure is an inability to excite the market.
Prior to the AIPAC results period they should have bought in some PR people with speccy biotech experience and done some serious work on how they were going to shift the messaging as the company moves into a new phase. It’s not a hard sell given what they are doing. Maybe that is starting to happen, we’ll see. But it’s an uphill battle when it doesn’t come naturally to the CEO or company culture.
I’ll give them the benefit of the doubt for now but I’d like to see a new approach develop over the next six months. It’s very important particularly in the light of the likely first LAG3 compound approval in March. Imm needs to maximize its exposure around this time and seize the moment.
- Forums
- ASX - By Stock
- IMM
- Marc Voight
Marc Voight, page-5
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.3¢ |
Change
0.003(0.81%) |
Mkt cap ! $454.5M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 30.5¢ | $101.8K | 327.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 119419 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 131000 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 115179 | 0.310 |
28 | 413302 | 0.305 |
23 | 459128 | 0.300 |
13 | 145879 | 0.295 |
15 | 329558 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 138627 | 21 |
0.320 | 161598 | 15 |
0.325 | 351880 | 8 |
0.330 | 41774 | 5 |
0.335 | 326676 | 6 |
Last trade - 11.47am 04/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |